Rik Saylor Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.64M Sell
20,678
-52
-0.3% -$6.49K 2.01% 14
2025
Q4
$2.53M Buy
+20,730
New +$2.38M 1.85% 18

Other funds holding XBI

Rik Saylor Financial's XBI Position: Q1 2026 in Review

Rik Saylor Financial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.25% in Q1 2026, selling an estimated $6.49K and leaving 20,678 shares worth $2.64M. The position accounts for 2.01% of the portfolio, ranked #14.

Rik Saylor Financial first reported a position in XBI in Q4 2025 and has held it in 2 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Rik Saylor Financial held 20,678 shares of State Street SPDR S&P Biotech ETF worth $2.64M as of Q1 2026.
  • Rik Saylor Financial sold 52 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $6.49K.
  • State Street SPDR S&P Biotech ETF made up 2.01% of Rik Saylor Financial's portfolio in Q1 2026, its #14 holding.
  • Rik Saylor Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 2 quarters since.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Rik Saylor Financial's 13F filing for Q1 2026, filed 8 May 2026.